Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties

US Patent 10011615 · Granted Jul 3, 2018

Estimated economic value: $73,356,000

Assignee

Inventors

View full patent text on Google Patents →